Skip to content

EnSite Precision™ 2.0 Registry

EnSite Precision™ Cardiac Mapping System and EnSite Precision™ Software v2.0 Observational Registry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02757430
Enrollment
515
Registered
2016-05-02
Start date
2016-08-30
Completion date
2017-07-15
Last updated
2019-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrhythmias

Brief summary

The objective of this registry is to assess and characterize the use and performance of the EnSite Precision™ Cardiac Mapping System and the EnSite Precision™ Software V2.0 in a variety of electrophysiological (EP) procedures and clinical settings. This registry will assess the clinical performance of the system in a controlled, real-world environment after commercial release. Up to 500 subjects will be enrolled in up to 50 sites worldwide. Data will be collected at enrollment/baseline, procedure and pre-discharge. There is no long-term follow-up required for this registry. The anticipated registry enrollment is about 6-7 months.

Detailed description

The use of the EnSite Precision™ Cardiac Mapping System will be assessed by collecting feedback from physicians/operators through specific questions. The performance of the EnSite Precision™ Cardiac Mapping System will be assessed by collecting procedure data and adverse events. A detailed Data Management Plan will be established to ensure consistency of the data. This document will include procedures used for data review, database cleaning, and issuing and resolving data queries. If appropriate, the Data Management Plan may be updated throughout the registry duration. All revisions will be tracked and document controlled. Case Report Form data will be captured in a validated electronic database management system hosted by St. Jude Medical. Centralized monitoring will occur through routine internal data review. This monitoring is designed to identify missing and inconsistent data, data outliers, and potential protocol deviations that may be indicative of site non-compliance. On-site monitoring may occur at the discretion of the sponsor.

Interventions

Sponsors

Abbott Medical Devices
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients indicated for a cardiac EP study and ablation procedure using a 3D mapping system * Over 18 years of age * Ability to provide informed consent for registry participation and be willing and able to comply with the protocol described evaluations

Exclusion criteria

* Contraindication to anticoagulation * Presence of thrombus * Implanted with mechanical prosthetic heart valve * Recent (\<3 months) myocardial Infarction or unstable angina or coronary artery by-pass * Pregnant or nursing * Individuals whose willingness to volunteer in a registry, in the judgment of investigator or public authorities, could be unduly influenced by lack of or loss of the autonomy due to immaturity, or mental disability, or adverse personal circumstances, or hierarchical influence

Design outcomes

Primary

MeasureTime frameDescription
Assessment of the EnSite Precision™ Software V2.0 in Terms of Unrecoverable Shiftsduring proceduresummarizing the count and percentage of patients with unrecoverable shifts
Point Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Cathetersduring proceduremapping points collected and used will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate)
Assessment of the EnSite Precision™ Software V2.0 in Terms of System Stabilityduring proceduresummarizing the count and percentage of patients with overall system stability
Assessment of the EnSite Precision™ Software V2.0 in Terms of Geometry Accuracyduring proceduresummarizing the count and percentage of patients with accurate geometry
Mapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Cathetersduring proceduremapping time will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate) for the following modules: Manual AutoMap™ TurboMap™
Mapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With Manual Mappingduring proceduremapping time will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate) for the following modules: Manual
Mapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With AutoMap Module Mappingduring proceduremapping time will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate) for the following modules: AutoMap module
Mapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With TurboMap Module Mappingduring proceduremapping time will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate) for the following modules: TurboMap module

Secondary

MeasureTime frameDescription
Clinical Utility and Ease of Use of the Automated Radiofrequency Marker Placementduring procedureCount and percentage of subjects where the AutoMark feature assisted in identifying gaps in lesion lines
EnSite Precision™ Cardiac Mapping System Assessmentduring procedureCount and percentage of subjects in whom the mapping system was reported to be excellent, very good, good, poor and N/A

Countries

Italy

Participant flow

Recruitment details

Any patient indicated to undergo a cardiac electrophysiology (EP) mapping and ablation procedure that used the EnSite Precision™ Cardiac Mapping System was considered eligible.

Participants by arm

ArmCount
Subjects With EnSite Precision™ Cardiac Mapping
Any patient indicated to undergo a cardiac EP mapping and ablation procedure that used the EnSite Precision™ Cardiac Mapping System was considered eligible. Subjects meeting all inclusion criteria and not meeting any exclusion criteria were enrolled in the study.
503
Total503

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyInclusion/Exclusion criteria not met3
Overall StudyNo informed consent1
Overall StudyNo procedure performed2
Overall StudyPhysician Decision6

Baseline characteristics

CharacteristicSubjects With EnSite Precision™ Cardiac Mapping
Age, Continuous59.6 years
STANDARD_DEVIATION 13.2
Ejection Fraction
Abnormal per physician/standard of care
285 Participants
Ejection Fraction
Normal per physician/standard of care
96 Participants
Ejection Fraction
Not Available
1 Participants
Ejection Fraction
Not Evaluated
121 Participants
Ejection Fraction54.2 %
STANDARD_DEVIATION 12
Indication for Procedure
Atrial Fibrillation
277 Participants
Indication for Procedure
Atrial Flutter
67 Participants
Indication for Procedure
Other
46 Participants
Indication for Procedure
Supraventricular Tachycardia
96 Participants
Indication for Procedure
Ventricular Tachycardia
56 Participants
Left Atrial Diameter43.1 mm
STANDARD_DEVIATION 8.3
Left Atrial Volume82.3 ml
STANDARD_DEVIATION 42.7
NYHA Heart Failure Classification
Class I
108 Participants
NYHA Heart Failure Classification
Class II
59 Participants
NYHA Heart Failure Classification
Class III
16 Participants
NYHA Heart Failure Classification
Class IV
1 Participants
NYHA Heart Failure Classification
Not Available
2 Participants
NYHA Heart Failure Classification
Not Evaluated
317 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Austria
23 Participants
Region of Enrollment
Belgium
2 Participants
Region of Enrollment
Finland
13 Participants
Region of Enrollment
France
159 Participants
Region of Enrollment
Germany
63 Participants
Region of Enrollment
Italy
172 Participants
Region of Enrollment
Netherlands
69 Participants
Region of Enrollment
United Kingdom
2 Participants
Sex: Female, Male
Female
179 Participants
Sex: Female, Male
Male
324 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 503
other
Total, other adverse events
2 / 503
serious
Total, serious adverse events
10 / 503

Outcome results

Primary

Assessment of the EnSite Precision™ Software V2.0 in Terms of Geometry Accuracy

summarizing the count and percentage of patients with accurate geometry

Time frame: during procedure

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Subjects With EnSite Precision™ Cardiac MappingAssessment of the EnSite Precision™ Software V2.0 in Terms of Geometry AccuracyGeometry found was anatomically accurate461 Participants
Subjects With EnSite Precision™ Cardiac MappingAssessment of the EnSite Precision™ Software V2.0 in Terms of Geometry AccuracyGeometry found was not anatomically accurate34 Participants
Subjects With EnSite Precision™ Cardiac MappingAssessment of the EnSite Precision™ Software V2.0 in Terms of Geometry AccuracyGeometry anatomical accuracy not available8 Participants
Primary

Assessment of the EnSite Precision™ Software V2.0 in Terms of System Stability

summarizing the count and percentage of patients with overall system stability

Time frame: during procedure

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Subjects With EnSite Precision™ Cardiac MappingAssessment of the EnSite Precision™ Software V2.0 in Terms of System StabilitySystem was stable throughout the procedure455 Participants
Subjects With EnSite Precision™ Cardiac MappingAssessment of the EnSite Precision™ Software V2.0 in Terms of System StabilitySystem was not stable throughout the procedure46 Participants
Subjects With EnSite Precision™ Cardiac MappingAssessment of the EnSite Precision™ Software V2.0 in Terms of System StabilityStability throughout the procedure not available2 Participants
Primary

Assessment of the EnSite Precision™ Software V2.0 in Terms of Unrecoverable Shifts

summarizing the count and percentage of patients with unrecoverable shifts

Time frame: during procedure

Population: 46 procedures with system not stable throughout the procedure

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Subjects With EnSite Precision™ Cardiac MappingAssessment of the EnSite Precision™ Software V2.0 in Terms of Unrecoverable ShiftsMap could be recovered36 Participants
Subjects With EnSite Precision™ Cardiac MappingAssessment of the EnSite Precision™ Software V2.0 in Terms of Unrecoverable ShiftsMap could not be recovered10 Participants
Primary

Mapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters

mapping time will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate) for the following modules: Manual AutoMap™ TurboMap™

Time frame: during procedure

Population: 603 total maps were created in 421 subjects.

ArmMeasureGroupValue (MEAN)Dispersion
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersManual Map14.2 minStandard Deviation 13.9
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersAutoMap13.1 minStandard Deviation 11.9
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersTurboMap6.6 minStandard Deviation 5.7
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersOther4.0 minStandard Deviation 1.4
Primary

Mapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With AutoMap Module Mapping

mapping time will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate) for the following modules: AutoMap module

Time frame: during procedure

Population: 526 total AutoMap Module maps were created.

ArmMeasureGroupValue (MEAN)Dispersion
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With AutoMap Module MappingAtrial Fibrillation11.3 minStandard Deviation 5.4
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With AutoMap Module MappingAtrial Flutter10.1 minStandard Deviation 7.3
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With AutoMap Module MappingSinus Rhythm14.3 minStandard Deviation 13.5
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With AutoMap Module MappingAtrial Tachycardia8.4 minStandard Deviation 5.8
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With AutoMap Module MappingAtrioventricular Reentry Tachycardia6.0 min
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With AutoMap Module MappingAtrioventricular Nodal Reentry Tachycardia11.0 minStandard Deviation 1.4
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With AutoMap Module MappingVentricular Tachycardia16.3 minStandard Deviation 16.2
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With AutoMap Module MappingOther14.3 minStandard Deviation 10.8
Primary

Mapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With Manual Mapping

mapping time will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate) for the following modules: Manual

Time frame: during procedure

Population: 62 total Manual maps were created.

ArmMeasureGroupValue (MEAN)Dispersion
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With Manual MappingSinus Rhythm11.5 minStandard Deviation 9.8
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With Manual MappingAtrial Fibrillation20.0 min
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With Manual MappingAtrial Flutter8.8 minStandard Deviation 4.3
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With Manual MappingAtrial Tachycardia18.3 minStandard Deviation 18.2
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With Manual MappingAtrioventricular Reentry Tachycardia10.0 minStandard Deviation 0
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With Manual MappingAtrioventricular Nodal Reentry Tachycardia3.6 minStandard Deviation 3.3
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With Manual MappingVentricular Tachycardia23.4 minStandard Deviation 19.3
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With Manual MappingOther14.6 minStandard Deviation 11.6
Primary

Mapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With TurboMap Module Mapping

mapping time will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate) for the following modules: TurboMap module

Time frame: during procedure

Population: 13 total TurboMap Module maps were created.

ArmMeasureGroupValue (MEAN)Dispersion
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With TurboMap Module MappingSinus Rhythm4.3 minStandard Deviation 1.2
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With TurboMap Module MappingAtrial Fibrillation17.0 min
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With TurboMap Module MappingAtrial Flutter3.3 minStandard Deviation 0.5
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With TurboMap Module MappingAtrial Tachycardia8.0 minStandard Deviation 9.9
Subjects With EnSite Precision™ Cardiac MappingMapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With TurboMap Module MappingOther9.0 minStandard Deviation 7.2
Primary

Point Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters

mapping points collected and used will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate)

Time frame: during procedure

Population: 606 total maps with mapping points used available were created in 421 subjects.

ArmMeasureGroupValue (MEAN)Dispersion
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersAll Arrhythmias781.9 mapping points usedStandard Deviation 1062.1
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersSinus Rhythm954.5 mapping points usedStandard Deviation 1245.6
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersAtrial Fibrillation1127.3 mapping points usedStandard Deviation 801.6
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersAtrial Flutter828.8 mapping points usedStandard Deviation 983.4
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersAtrial Tachycardia612.3 mapping points usedStandard Deviation 663.6
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersAtrioventricular Reentry Tachycardia85.5 mapping points usedStandard Deviation 103.9
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersArioventricular Nodal Reentry Tachycardia56.7 mapping points usedStandard Deviation 134.2
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersVentricular Tachycardia318.1 mapping points usedStandard Deviation 623.7
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersOther104.3 mapping points usedStandard Deviation 182.6
Primary

Point Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters

mapping points collected and used will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate)

Time frame: during procedure

Population: 606 total maps with mapping points collected available were created in 421 subjects.

ArmMeasureGroupValue (MEAN)Dispersion
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersAll Arrhythmias2074.7 mapping points collectedStandard Deviation 3377.2
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersSinus Rhythm2396.0 mapping points collectedStandard Deviation 3638.5
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersAtrial Fibrillation3124.3 mapping points collectedStandard Deviation 3253.4
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersAtrial Flutter2484.3 mapping points collectedStandard Deviation 4440.9
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersAtrial Tachycardia1957.0 mapping points collectedStandard Deviation 2331
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersAtrioventricular Reentry Tachycardia143.5 mapping points collectedStandard Deviation 169
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersArioventricular Nodal Reentry Tachycardia95.0 mapping points collectedStandard Deviation 237.6
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersVentricular Tachycardia841.9 mapping points collectedStandard Deviation 1698.7
Subjects With EnSite Precision™ Cardiac MappingPoint Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of CathetersOther208.4 mapping points collectedStandard Deviation 438
Secondary

Clinical Utility and Ease of Use of the Automated Radiofrequency Marker Placement

Count and percentage of subjects where the AutoMark feature assisted in identifying gaps in lesion lines

Time frame: during procedure

Population: 117 subjects had gaps identified in the lesion line

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Subjects With EnSite Precision™ Cardiac MappingClinical Utility and Ease of Use of the Automated Radiofrequency Marker PlacementAutoMark assisted in identifying gaps34 Participants
Subjects With EnSite Precision™ Cardiac MappingClinical Utility and Ease of Use of the Automated Radiofrequency Marker PlacementAutoMark did not assist in identifying gaps83 Participants
Secondary

Clinical Utility and Ease of Use of the Automated Radiofrequency Marker Placement

Count and percentage of subjects where the AutoMark feature was easy to use

Time frame: during procedure

Population: 373 procedures used AutoMark

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Subjects With EnSite Precision™ Cardiac MappingClinical Utility and Ease of Use of the Automated Radiofrequency Marker PlacementAutoMark Feature ease of use not available17 Participants
Subjects With EnSite Precision™ Cardiac MappingClinical Utility and Ease of Use of the Automated Radiofrequency Marker PlacementAutoMark feature was easy to use352 Participants
Subjects With EnSite Precision™ Cardiac MappingClinical Utility and Ease of Use of the Automated Radiofrequency Marker PlacementAutoMark feature was not easy to use4 Participants
Secondary

EnSite Precision™ Cardiac Mapping System Assessment

Count and percentage of subjects in whom the mapping system was reported to be excellent, very good, good, poor and N/A

Time frame: during procedure

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Subjects With EnSite Precision™ Cardiac MappingEnSite Precision™ Cardiac Mapping System AssessmentExcellent153 Participants
Subjects With EnSite Precision™ Cardiac MappingEnSite Precision™ Cardiac Mapping System AssessmentVery Good202 Participants
Subjects With EnSite Precision™ Cardiac MappingEnSite Precision™ Cardiac Mapping System AssessmentGood139 Participants
Subjects With EnSite Precision™ Cardiac MappingEnSite Precision™ Cardiac Mapping System AssessmentPoor8 Participants
Subjects With EnSite Precision™ Cardiac MappingEnSite Precision™ Cardiac Mapping System AssessmentNot Applicable1 Participants
Secondary

EnSite Precision™ Cardiac Mapping System Assessment

Overall procedure time summarized using mean and standard deviation

Time frame: during procedure

Population: 501 subjects had procedure time available

ArmMeasureValue (MEAN)Dispersion
Subjects With EnSite Precision™ Cardiac MappingEnSite Precision™ Cardiac Mapping System Assessment116.8 minsStandard Deviation 52.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026